Cyclexanone
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162619This classification denotes an antitussive agent with the molecular formula C16H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 2OU4KS37EO, chemically known as 4(5h)-oxazolone, 2-(cyclopropylamino)-5-phenyl- (9ci) but more generally known as cyclexanone, which bears US NIH Compound Identifier 26701. European Medicines Agency schedules Cyclexanone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06845MIG. The term CYCLEXANONE is an International Non-Proprietary Name. CYCLEXANONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule cyclexanone under HS 29349990 and SITC 51579. As of Q4 2014, CYCLEXANONE remains US FDA's Preferred Term for this commodity. Cyclexanone bears US NLM identifiers UMLS ID C2699484 and NCI Concept Code C78108. SMILES: O1C(=NC(=O)C1C1CCCCC1)NC1CC1.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.